Treatment of lymphocytic hypophysitis by high-dose methylprednisolone pulse therapy

被引：44

作者：

Yamagami, K ^{[1
]}

Yoshioka, K ^{[1
]}

Sakai, H ^{[1
]}

Fukumoto, M ^{[1
]}

Yamakita, T ^{[1
]}

Hosoi, M ^{[1
]}

Ishii, T ^{[1
]}

Sato, T ^{[1
]}

Tanaka, S ^{[1
]}

Fujii, S ^{[1
]}

机构：

[1] Osaka City Gen Hosp, Dept Internal Med, Osaka 5340021, Japan

来源：

INTERNAL MEDICINE | 2003年 / 42卷 / 02期

关键词：

lymphocytic hypophysitis; high dose methylprednisolone; pulse therapy; pituitary mass; visual disturbance; magnetic resonance imaging;

D O I：

10.2169/internalmedicine.42.168

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 26-year-old woman 3 months post-partum was admitted to our hospital suffering from gross visual disturbance. Magnetic resonance imaging (MRI) revealed a pituitary mass, extending into the suprasellar cistern, with intense gadolinium enhancement. Lymphocytic hypophysitis (LHy) was suspected, and the patient received high dose methylprednisolone pulse therapy (HDMPT). Her visual disturbance was dramatically ameliorated on the first day following initiation of HDMPT, and MRI revealed marked mass reduction. Her pituitary function recovered 6 months after therapy. This case report suggests that HDMPT proved effective for mass reduction of severe LHy and could obviate the need for a useless surgery.

引用

下载

页码：168 / 173

页数：6

共 50 条

[31] In vitro evidence that treatment with high dose methylprednisolone pulse therapy is superior to high dose prednisolone or dexamethasone
Remans, P. H. J.
Gerlag, D. M.
Wijbrandts, C. A.
Reedquist, K. A.
Tak, P. P.
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A47 - A47
[32] High-dose oral methylprednisolone therapy in childhood hemangiomas
Uysal, KM
Olgun, N
Erbay, A
Sarialioglu, F
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2001, 18 (05) : 335 - 341
[33] BRADYCARDIA AFTER HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE THERAPY
TVEDE, N
NIELSEN, LP
ANDERSEN, V
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, 15 (03) : 302 - 304
[34] HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY IN PATIENTS WITH RHEUMATOID DISEASE - PLASMA METHYLPREDNISOLONE LEVELS AND ADRENAL-FUNCTION
BAYLIS, EM
WILLIAMS, IA
ENGLISH, J
MARKS, V
CHAKRABORTY, J
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) : 385 - 388
[35] Side-effects of high-dose intravenous (pulse) methylprednisolone therapy cured by potassium infusion
Bonnotte, B
Chauffert, B
Martin, F
Lorcerie, B
BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (01): : 109 - 109
[36] CLINICAL EFFICACY OF HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
KIMBERLY, R
LOCKSHIN, M
SHERMAN, R
MCDOUGAL, JS
INMAN, R
CHRISTIAN, CL
ARTHRITIS AND RHEUMATISM, 1979, 22 (06): : 629 - 629
[37] Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia
Pileckyte, Regina
Jurgutis, Mindaugas
Valceckiene, Vilma
Stoskus, Mindaugas
Gineikiene, Egle
Sejoniene, Jurgita
Degulys, Andrius
Zvirblis, Tadas
Griskevicius, Laimonas
LEUKEMIA & LYMPHOMA, 2011, 52 (06) : 1055 - 1065
[38] Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia
Castro, J. E.
Sandoval-Sus, J. D.
Bole, J.
Rassenti, L.
Kipps, T. J.
LEUKEMIA, 2008, 22 (11) : 2048 - 2053
[39] Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia
J E Castro
J D Sandoval-Sus
J Bole
L Rassenti
T J Kipps
Leukemia, 2008, 22 : 2048 - 2053
[40] EFFICACIOUS EXPERIMENTAL STROKE TREATMENT WITH HIGH-DOSE METHYLPREDNISOLONE
DECOURTENMYERS, GM
KLEINHOLZ, M
WAGNER, KR
XI, GH
MYERS, RE
STROKE, 1994, 25 (02) : 487 - 492

← 1 2 3 4 5 →